Close Menu

NEW YORK (GenomeWeb) – Phoenix-based tumor profiling firm Paradigm Diagnostics has signed an exclusive distribution agreement with IDB Resources for Malaysia, Singapore, and Brunei.

Under the terms of the agreement, Malaysia-based IDB Resources will provide access to Paradigm's PCDx next-generation sequencing clinical tumor profiling service. The test offers information on potential therapies based on the characterization of the patient's tumor genome.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics. 

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.